The Barbara Ann Karmanos Cancer Institute, headquartered in Detroit, is the largest cancer research and provider network in Michigan and has 16 treatment locations. It is one of 51 National Cancer Institute-designated comprehensive cancer treatment and research centers in the United States.

There are 123 beds in Barbara Ann Karmanos Cancer Institute.

During the past decade, Barbara Ann Karmanos Cancer Institute conducted 379 clinical trials. In the 10-year time frame, 379 clinical trials started and 278 clinical trials were completed, i.e. on average, 73.4% percent of trials that started reached the finish line to date. In the past 5 years, 139 clinical trials started and 130 clinical trials were completed. i.e. 93.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barbara Ann Karmanos Cancer Institute" #1 sponsor was "Barbara Ann Karmanos Cancer Institute" with 117 trials, followed by "SWOG Cancer Research Network" with 105 trials sponsored, "Radiation Therapy Oncology Group" with 54 trials sponsored, "Pfizer" with 35 trials sponsored and "Children's Oncology Group" with 35 trials sponsored. Other sponsors include 620 different institutions and companies that sponsored additional 269 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barbara Ann Karmanos Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 379 trials as a collaborator, "Cancer and Leukemia Group B" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 18 trials as a collaborator, "Eastern Cooperative Oncology Group" with 14 trials as a collaborator and "Merck Sharp & Dohme LLC" with 14 trials as a collaborator. Other collaborators include 323 different institutions and companies that were collaborators in the rest 179 trials.

According to Clinical.Site data, the most researched conditions in "Barbara Ann Karmanos Cancer Institute" are "Breast Cancer" (64 trials), "Prostate Cancer" (53 trials), "Multiple Myeloma" (49 trials), "Lung Cancer" (47 trials) and "Lymphoma" (47 trials). Many other conditions were trialed in "Barbara Ann Karmanos Cancer Institute" in a lesser frequency.

Most popular intervention types in "Barbara Ann Karmanos Cancer Institute" are "Drug" (809 trials), "Biological" (162 trials), "Procedure" (121 trials), "Radiation" (113 trials) and "Other" (97 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (74 trials), "cisplatin" (51 trials), "Placebo" (45 trials), "paclitaxel" (44 trials) and "cyclophosphamide" (42 trials). Other intervention names were less common.

The vast majority of trials in "Barbara Ann Karmanos Cancer Institute" are 791 trials for "All" genders, 100 trials for "Female" genders and 77 trials for "Male" genders.

Currently, there are NaN active trials in "Barbara Ann Karmanos Cancer Institute". undefined are not yet recruiting, 106 are recruiting, 103 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 594 completed trials in Barbara Ann Karmanos Cancer Institute, 4 suspended trials, and 129 terminated clinical trials to date.

Out of the total trials that were conducted in Barbara Ann Karmanos Cancer Institute, 300 "Phase 1" clinical trials were conducted, 479 "Phase 2" clinical trials and 211 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 49 trials that are defined as “Not Applicable".

Barbara Ann Karmanos Cancer Institute has several departments that took part in Clinical trials: "McLaren Cancer Institute-Flint" - 129 trials, "McLaren Cancer Institute-Macomb" - 75 trials, "Weisberg Cancer Treatment Center" - 183 trials, "Karmanos cancer Center" - 71 trials, "McLaren Cancer Institute-Northern Michigan" - 69 trials, "McLaren Cancer Institute-Bay City" - 59 trials, "McLaren Cancer Institute-Lapeer Region" - 56 trials, "McLaren Cancer Institute-Clarkston" - 50 trials, "McLaren Cancer Institute-Central Michigan" - 46 trials, "Karmanos Cancer Institute at McLaren Greater Lansing" - 36 trials, "McLaren Cancer Institute - Bloomfield" - 12 trials, "Great Lakes Cancer Institute - Lapeer Campus" - 10 trials, "Karmanos Cancer Institute/BMT" - 7 trials, "Karmanos Cancer Institute, Children's Hospital of Michigan" - 4 trials, "Lawrence and Idell Weisberg Cancer Treatment Center" - 2 trials